Annual CFF
$0.00
+$102.10 K+100.00%
31 December 2023
Summary:
Context Therapeutics annual cash flow from financing activities is currently $0.00, with the most recent change of +$102.10 thousand (+100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$1.15 million (-100.00%). CNTX annual CFF is now -100.00% below its all-time high of $58.39 million, reached on 31 December 2021.CNTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$44.60 K
-$94.85 M-100.05%
01 September 2024
Summary:
Context Therapeutics quarterly cash flow from financing activities is currently -$44.60 thousand, with the most recent change of -$94.85 million (-100.05%) on 01 September 2024. Over the past year, it has dropped by -$44.60 thousand (-100.00%). CNTX quarterly CFF is now -100.05% below its all-time high of $94.80 million, reached on 30 June 2024.CNTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$94.76 M
-$44.60 K-0.05%
01 September 2024
Summary:
Context Therapeutics TTM cash flow from financing activities is currently $94.76 million, with the most recent change of -$44.60 thousand (-0.05%) on 01 September 2024. Over the past year, it has increased by +$94.76 million (+100.00%). CNTX TTM CFF is now -0.05% below its all-time high of $94.80 million, reached on 30 June 2024.CNTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -100.0% | +100.0% |
| 3 y3 years | -100.0% | +94.5% | +1998.3% |
| 5 y5 years | - | - | - |
CNTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +100.0% | -100.0% | +94.5% | -0.1% | >+9999.0% |
| 5 y | 5 years | -100.0% | +100.0% | -100.0% | +94.5% | -0.1% | >+9999.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +94.5% | -0.1% | >+9999.0% |
Context Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$44.60 K(-100.0%) | $94.76 M(-0.0%) |
| June 2024 | - | $94.80 M(>+9900.0%) | $94.80 M(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | -$102.10 K(-100.2%) | $0.00(0.0%) | -$102.10 K(-100.2%) |
| Sept 2022 | - | $0.00(0.0%) | $54.13 M(+1.5%) |
| June 2022 | - | $0.00(-100.0%) | $53.31 M(-3.5%) |
| Mar 2022 | - | -$102.10 K(-100.2%) | $55.26 M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $58.39 M(+4981.7%) | $54.23 M(-6738.3%) | $58.39 M(+1193.1%) |
| Sept 2021 | - | -$816.90 K(-141.9%) | $4.52 M(-21.9%) |
| June 2021 | - | $1.95 M(-35.8%) | $5.78 M(+39.1%) |
| Mar 2021 | - | $3.03 M(+767.0%) | $4.16 M(+261.9%) |
| Dec 2020 | $1.15 M(-41.3%) | $350.00 K(-22.2%) | $1.15 M(+43.8%) |
| Sept 2020 | - | $450.00 K(+38.8%) | $799.10 K(+128.9%) |
| June 2020 | - | $324.10 K(+1196.4%) | $349.10 K(+1296.4%) |
| Mar 2020 | - | $25.00 K | $25.00 K |
| Dec 2019 | $1.96 M | - | - |
FAQ
- What is Context Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Context Therapeutics?
- What is Context Therapeutics annual CFF year-on-year change?
- What is Context Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Context Therapeutics?
- What is Context Therapeutics quarterly CFF year-on-year change?
- What is Context Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Context Therapeutics?
- What is Context Therapeutics TTM CFF year-on-year change?
What is Context Therapeutics annual cash flow from financing activities?
The current annual CFF of CNTX is $0.00
What is the all time high annual CFF for Context Therapeutics?
Context Therapeutics all-time high annual cash flow from financing activities is $58.39 M
What is Context Therapeutics annual CFF year-on-year change?
Over the past year, CNTX annual cash flow from financing activities has changed by +$102.10 K (+100.00%)
What is Context Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CNTX is -$44.60 K
What is the all time high quarterly CFF for Context Therapeutics?
Context Therapeutics all-time high quarterly cash flow from financing activities is $94.80 M
What is Context Therapeutics quarterly CFF year-on-year change?
Over the past year, CNTX quarterly cash flow from financing activities has changed by -$44.60 K (-100.00%)
What is Context Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CNTX is $94.76 M
What is the all time high TTM CFF for Context Therapeutics?
Context Therapeutics all-time high TTM cash flow from financing activities is $94.80 M
What is Context Therapeutics TTM CFF year-on-year change?
Over the past year, CNTX TTM cash flow from financing activities has changed by +$94.76 M (+100.00%)